![Cetaphil](/sites/default/files/Cetaphil_Logo.jpg)
16 . 02 .2023
Press release
Cetaphil raises awareness of the connection between clothing and sensitive skin
![Alastin_ReSurface](/sites/default/files/Website_AlastinReSurface.png)
06 . 02 .2023
Press release
Galderma Launches Cutting-Edge Formulation With Alastin Skincare® Resurface Skin Polish Developed To Uncover Visibly Glowing Skin
![Face By Galderma Before After](/sites/default/files/BeforeAfter_News.jpg)
26 . 01 .2023
Press release
Galderma announces the launch of FACE by Galderma™ – a game-changing augmented reality solution helping healthcare professionals grow their activity and improve patient satisfaction
![](/sites/default/files/Galderma_Poster_Landscape3.png)
23 . 01 .2023
Press release
Galderma expands footprint with new Global Capability Center in Barcelona to support global growth
![](/sites/default/files/LINKEDIN%20POST_Curtain%20Raiser.jpg)
20 . 01 .2023
Press release
IMCAS 2023: Galderma to share latest data demonstrating high aesthetic improvement and patient satisfaction across its innovative portfolio
![](/sites/default/files/Mosaic_def.png)
13 . 01 .2023
Press release
"The Full Spectrum of Dermatology: A Diverse And Inclusive Atlas" Launches New, Free Online Image Gallery
![](/sites/default/files/Flemming_Mayor_Johnson.jpg)
09 . 12 .2022
News story
Galderma, the pure-play dermatology category leader and maker of Cetaphil, celebrates grand opening of U.S. headquarters in Dallas
![](/sites/default/files/WEBSITE%20NEWS%20TOP%20IMAGE%20%281%29.png)
16 . 11 .2022
News story
Sales data confirm Galderma’s range of anti-acne products is the No.1 choice globally
17 . 10 .2022
Press release
Galderma launches novel formulation with Alastin Skincare® A-Luminate Brightening Serum® developed to diminish the appearance of hyperpigmentation
![](/sites/default/files/Frame%2014%20%282%29.png)
13 . 10 .2022
Press release
Galderma announces intention to expand manufacturing and innovation footprint in Asia-Pacific